LLY ELI LILLY & CO

2026Q1 · CUSIP 532457108 · GLP-1 / Weight Loss · Sector: Healthcare & Biotech

Danger · Dual-confirm: breadth + price

Holders

4,353

Δ holders QoQ

-78

Breadth percentile

Top 99%

Whale holders

384

Δ whales

-3

Inst. holding value

$700.3B

New positions

239

Closed positions

317

Price momentum (1Q)

-4.5%

Put / Call

73/62

Breadth history (34 quarters)

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 0%	-4.5%	—
2025Q1	Top 15%	-6.7%	+35.8%
2024Q4	Top 1%	-11.7%	-17.6%
2024Q3	Top 1%	+20.4%	-1.3%
2024Q2	Top 1%	-14.7%	-5.7%
2024Q1	Top 0%	+19.9%	-2.8%
2023Q4	Top 0%	-1.4%	+18.2%
2023Q3	Top 0%	+28.6%	+33.5%
2023Q2	Top 0%	+12.0%	+39.2%
2022Q4	Top 0%	+34.6%	+68.4%
2022Q3	Top 1%	-6.6%	+26.1%
2022Q2	Top 0%	+15.1%	+8.6%
2022Q1	Top 3%	+5.5%	+16.8%
2021Q4	Top 1%	+20.6%	+29.8%
2021Q3	Top 5%	-4.3%	+15.4%
2021Q2	Top 1%	-3.5%	-12.4%
2021Q1	Top 3%	+38.5%	+33.7%
2020Q4	Top 3%	-4.6%	+32.2%
2020Q2	Top 2%	-5.6%	+37.5%
2020Q1	Top 7%	-3.6%	-9.0%
2019Q4	Top 2%	+12.5%	+8.5%
2019Q3	Top 14%	+25.1%	+35.6%
2019Q1	Top 3%	-4.2%	-2.9%
2018Q4	Top 1%	-4.3%	-6.8%
2018Q3	Top 1%	+8.4%	+4.8%
2018Q2	Top 5%	+5.8%	+18.3%

Show all 26 events

Put holders

QoQ: -6

Call holders

QoQ: +4

See methodology →

PE (TTM)

40.9

EPS (TTM)

$28.15

EPS YoY

+129.1%

Revenue (TTM)

$72.2B

Revenue YoY

+47.4%

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)